7 days ago
LLY
AnalystsSrikripa DevarakondaSrikripa Devarakonda's Stock Forecasts
AnalystsSrikripa Devarakonda
Sectors:
Industries:
Analyst Ranking
Top 22%
#977 out of 4577 analysts
Average Return
+5.91%
Win Rate
37%11 out of 30
Risk vs Reward
Poor
Good
Srikripa Devarakonda's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Edgewise Therapeutics IncEWTX | +180.82% | $7.56 | $21.23 | 2023-06-27 - 2024-05-07 | Strong Buy |
9 Meters Biopharma IncNMTRQ | +91.97% | $11.46 | $22.00 | 2020-06-29 - 2021-06-30 | Strong Buy |
Edgewise Therapeutics IncEWTX | +87.66% | $9.56 | $17.94 | 2023-04-30 - 2024-04-30 | Strong Buy |
Verastem IncVSTM | +85.99% | $6.14 | $11.42 | 2023-11-14 - 2024-05-07 | Strong Buy |
Kymera Therapeutics IncKYMR | +67.20% | $22.99 | $38.44 | 2023-06-29 - 2024-05-07 | Strong Buy |
Srikripa Devarakonda Analyst Color
Get additional color on Srikripa Devarakonda's coverage of popular stocks
2 months ago
KYMR
Srikripa Devarakonda's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Incyte CorpINCY | 7 | Strong Buy | $83.00 | +52.66% | Reiterates | 7 days ago |
Eli Lilly & CoLLY | 1 | Strong Buy | $892.00 | +14.69% | Maintains | 7 days ago |
Edgewise Therapeutics IncEWTX | 4 | Strong Buy | $25.00 | +17.76% | Maintains | 21 days ago |
Cytokinetics IncCYTK | 3 | Strong Buy | $86.00 | +31.74% | Reiterates | a month ago |
Scholar Rock Holding CorpSRRK | 3 | Strong Buy | $20.00 | +36.15% | Reiterates | a month ago |
Keros Therapeutics IncKROS | 2 | Strong Buy | $100.00 | +70.42% | Reiterates | 2 months ago |
Kymera Therapeutics IncKYMR | 2 | Strong Buy | $54.00 | +40.48% | Maintains | 2 months ago |
Verastem IncVSTM | 5 | Strong Buy | $34.00 | +197.72% | Maintains | 6 months ago |
Affimed NvAFMD | 2 | Strong Buy | $60.00 | +1,047.23% | Maintains | 9 months ago |
9 Meters Biopharma IncNMTRQ | 3 | Hold | $38.00 | N/A | Downgrades | a year ago |
Constellation Pharmaceuticals IncCNST | 2 | Hold | $34.00 | N/A | Downgrades | 3 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.